Centersquare Investment Management LLC Sells 522,440 Shares of Ventas, Inc. $VTR

Centersquare Investment Management LLC reduced its position in shares of Ventas, Inc. (NYSE:VTR) by 7.5% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,484,117 shares of the real estate investment trust’s stock after selling 522,440 shares during the period. Ventas comprises about 4.6% of Centersquare Investment Management LLC’s investment portfolio, making the stock its 5th largest holding. Centersquare Investment Management LLC owned 1.38% of Ventas worth $453,823,000 at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Cloud Capital Management LLC acquired a new position in Ventas during the 3rd quarter worth approximately $25,000. True Wealth Design LLC raised its holdings in shares of Ventas by 1,557.7% in the third quarter. True Wealth Design LLC now owns 431 shares of the real estate investment trust’s stock valued at $30,000 after purchasing an additional 405 shares during the last quarter. ORG Partners LLC lifted its position in shares of Ventas by 76.1% in the third quarter. ORG Partners LLC now owns 456 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 197 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its holdings in Ventas by 65.5% during the third quarter. Wilmington Savings Fund Society FSB now owns 455 shares of the real estate investment trust’s stock worth $32,000 after purchasing an additional 180 shares during the last quarter. Finally, Golden State Wealth Management LLC boosted its holdings in Ventas by 52.7% during the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after purchasing an additional 185 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Monday, December 29th. Scotiabank lifted their target price on Ventas from $74.00 to $80.00 and gave the company a “sector perform” rating in a research report on Thursday, November 13th. Wells Fargo & Company increased their price target on Ventas from $80.00 to $88.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. KeyCorp increased their price target on Ventas from $85.00 to $90.00 and gave the company an “overweight” rating in a research report on Tuesday, February 10th. Finally, The Goldman Sachs Group reaffirmed a “buy” rating and set a $100.00 price target on shares of Ventas in a research report on Monday, February 9th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $86.87.

Ventas Price Performance

Shares of NYSE VTR opened at $86.41 on Thursday. The business’s 50 day moving average price is $79.72 and its two-hundred day moving average price is $74.87. The company has a market cap of $41.04 billion, a PE ratio of 160.02, a price-to-earnings-growth ratio of 2.11 and a beta of 0.77. The company has a quick ratio of 0.67, a current ratio of 0.67 and a debt-to-equity ratio of 1.03. Ventas, Inc. has a twelve month low of $60.15 and a twelve month high of $87.24.

Ventas (NYSE:VTR) last released its quarterly earnings data on Thursday, February 5th. The real estate investment trust reported $0.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.89 by ($0.74). The business had revenue of ($1,229.71) million during the quarter, compared to analyst estimates of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the previous year, the business earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. On average, analysts predict that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, April 16th. Stockholders of record on Tuesday, March 31st will be given a $0.52 dividend. The ex-dividend date of this dividend is Tuesday, March 31st. This is a boost from Ventas’s previous quarterly dividend of $0.48. This represents a $2.08 annualized dividend and a dividend yield of 2.4%. Ventas’s payout ratio is currently 355.56%.

Insider Transactions at Ventas

In other Ventas news, CEO Debra A. Cafaro sold 10,322 shares of the stock in a transaction dated Monday, February 2nd. The shares were sold at an average price of $77.66, for a total value of $801,606.52. Following the transaction, the chief executive officer directly owned 1,114,034 shares of the company’s stock, valued at $86,515,880.44. This represents a 0.92% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Robert F. Probst sold 29,930 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The stock was sold at an average price of $77.25, for a total transaction of $2,312,092.50. Following the sale, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This trade represents a 17.78% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is owned by insiders.

About Ventas

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.